InfuSystem stockholders elect all seven board nominees and approve say-on-pay and auditor ratification

Proposal No. 2: The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement as follows: For Against Abstain Broker Non-Votes 8,447,458 7,411,428 6,763 2,409,394

At the 2024 Annual Meeting of Stockholders of InfuSystem Holdings, Inc. (the "Company") held on May 16, 2024 , the matters voted upon and the number of votes for, against or withheld, as well as the number of abstentions and broker non-votes as to such matters, were as stated below: Proposal No. 1: The Company's Board Nominees For Withheld Broker Non-Votes Ralph Boyd 10,321,961 5,543,688 2,409,394 Richard DiIorio 12,564,229 3,301,420 2,409,394 Kenneth Eichenbaum 11,444,647 4,421,002 2,409,394 Paul Gendron 11,366,680 4,498,969 2,409,394 Beverly Huss 10,958,717 4,906,932 2,409,394 Carrie Lachance 12,443,248 3,422,401 2,409,394 Scott Shuda 9,810,697 6,054,952 2,409,394 All seven of the Company's Board nominees (Messrs. Boyd, DiIorio, Eichenbaum, Gendron and Shuda and Mss. Huss and Lachance) were elected to the Board.

Proposal No. 3: The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's registered independent accounting firm for the fiscal year ending December 31, 2024 as follows: For Against Abstain Broker Non-Votes 16,164,598 1,930,216 180,229 0